Sales Alterar Data
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
Acorda Therapeutics USD 27.72M 1.96M 2023-09
Agios Pharmaceuticals USD 7.1M 296K 2023-12
Akebia Therapeutics USD 42.05M 14.33M 2023-09
Alnylam Pharmaceuticals USD 439.72M 310.81M 2023-12
Anika Therapeutics USD 41.46M 2.84M 2023-09
Arrowhead Research USD 3.55M 12.55M 2023-12
AstraZeneca USD 12.02B 532M 2023-12
Bluebird Bio USD 12.39M 5.5M 2023-09
Bristol-Myers Squibb USD 11.48B 511M 2023-12
Eli Lilly USD 9.35B 145.2M 2023-12
Enanta Pharmaceuticals USD 18M 929K 2023-12
Esperion Therapeutics USD 32.25M 1.72M 2023-12
Halozyme Therapeutics USD 230.04M 14.01M 2023-12
Heron Therapeutics USD 31.43M 328K 2023-09
Insmed USD 83.69M 4.62M 2023-12
J&J USD 21.4B 44M 2023-12
Lexicon Pharmaceuticals USD 162K 155K 2023-09
Ligand Pharmaceuticals USD 28.1M 4.77M 2023-12
Merck USD 14.63B 1.33B 2023-12
Minerva Neurosciences USD 0 0 2021-12
Moderna USD 2.81B 980M 2023-12
Novartis USD 11.78B 316M 2023-12
Pfizer USD 14.25B 1.02B 2023-12
PTC Therapeutics USD 307.06M 110.48M 2023-12
Puma Biotechnology USD 72.18M 16.06M 2023-12
Sangamo BioSciences USD 9.4M 2.56M 2023-09
Sanofi EUR 10.92B 1.05B 2023-12
Takeda JPY 1.11T 68.1B 2023-12
Teva Pharmaceutical Industries USD 4.46B 607M 2023-12
Ultragenyx Pharmaceutical USD 127.39M 29.34M 2023-12
Vanda Pharmaceuticals USD 45.27M 6.46M 2023-12
Veracyte USD 98.2M 8.09M 2023-12



Vanda Pharmaceuticals Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.